Techno MedicaTechno Medica Co., Ltd.6678東証スタンダード電気機器FY ending Mar 2026, non-consolidated, J-GAAP
Out of every ¥100 of sales, about ¥15 is left as operating profit. Revenue changed +13.4% from the prior year, operating profit +28.3%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 13.2% | 0.52× | 6.9% | 1.18× | 8.2% |
| 2023 | 12.3% | 0.49× | 6.1% | 1.18× | 7.2% |
| 2024 | 13.1% | 0.56× | 7.3% | 1.22× | 8.9% |
| 2025 | 10.1% | 0.56× | 5.7% | 1.25× | 7.1% |
| 2026 | 9.5% | 0.63× | 6.0% | 1.25× | 7.4% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 9,699 | 9,368 | 10,284 | 9,906 | 11,237 |
| Cost of revenue | 4,882 | 4,737 | 5,131 | 4,978 | 5,994 |
| Gross profit | 4,817 | 4,630 | 5,152 | 4,928 | 5,243 |
| SG&A | 2,955 | 2,981 | 3,312 | 3,628 | 3,574 |
| Operating income | 1,862 | 1,649 | 1,840 | 1,300 | 1,668 |
| Pretax income | 1,851 | 1,666 | 1,861 | 1,320 | 1,525 |
| Income tax | 570 | 515 | 512 | 315 | 454 |
| Net income attributable to owners | 1,281 | 1,151 | 1,348 | 1,005 | 1,071 |
| Operating margin | 19.2% | 17.6% | 17.9% | 13.1% | 14.8% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥11.5B | ¥11.8B | ¥8.59B | ¥9.06B | ¥8.98B |
| Total assets | ¥18.5B | ¥19.4B | ¥17.4B | ¥17.9B | ¥18B |
| Net assets | ¥15.7B | ¥16.4B | ¥13.8B | ¥14.4B | ¥14.4B |
| Share capital | ¥1.07B | ¥1.07B | ¥1.07B | ¥1.07B | ¥1.07B |
| Property, plant and equipment | ¥1.49B | ¥1.53B | ¥1.45B | ¥1.4B | ¥1.35B |
| Intangible assets excluding goodwill | ¥33M | ¥23M | ¥71.3M | ¥59.8M | ¥47M |
| Current assets | ¥16.5B | ¥17.3B | ¥15.1B | ¥15.7B | ¥15.7B |
| Current liabilities | ¥2.63B | ¥2.81B | ¥3.36B | ¥3.28B | ¥3.08B |
| Total liabilities | ¥2.86B | ¥3.06B | ¥3.62B | ¥3.55B | ¥3.56B |
| Equity attributable to owners of parent | ¥15.7B | ¥16.4B | ¥13.8B | ¥14.4B | ¥14.4B |
| Retained earnings | ¥14.3B | ¥14.9B | ¥15.7B | ¥16.3B | ¥16.9B |
| Treasury stock | -¥648.6M | -¥541.8M | -¥3.98B | -¥3.94B | -¥4.51B |
EDINET (FSA Japan)
有価証券報告書－第39期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第38期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第37期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第36期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第35期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第34期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 44 / Derived from other figures: 2
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.